← Leaderboards
Audrey Ragan Odom John
Washington University
$12,417,124
Attributed
$19,532,829
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,532,829 · 11
By mechanism
R01$11,850,963 · 3
R33$2,894,767 · 1
R61$1,750,391 · 1
R21$1,398,200 · 3
T32$1,004,651 · 1
K08$512,081 · 1
Top collaborators
- Andrew Leon Kau6 shared
- Hamid Bassiri4 shared
- Cynthia Schieck Dowd4 shared
- Harvey Michael Friedman4 shared
- Joseph Martin Jez4 shared
Most similar at Washington University
Same institution · by research overlap
- Neelendu Dey$2,819,191
- Joseph Martin Jez$3,291,889
- Mark E. Lowe$21,007,137
- Nathan E Wolins$1,652,830
- Vijay Sharma$15,781,488
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularAnabolismMalariaDrug DevelopmentBiologicalPlasmodium FalciparumInnovationParasitesPathogenChildhoodMetabolic PathwayCessation Of LifeAntimalarialsPathway InteractionsIsoprenoidEnzymesFosmidomycinCharacteristicsFuturePublic HealthBiologyEnsureMetabolismBase
Grant awards (42)
Structure-based microbially targeted prodrugs$1,535,250
R01 · FY2025 · AI · contact PI
Breathprinting as a window into gut microbiome chemoecology$628,534
R01 · FY2025 · HD · contact PI
MEP pathway resistance in Plasmodium falciparum$452,870
R01 · FY2025 · AI · contact PI
Combined Adult and Pediatric Infectious Disease Postdoctoral Training Grant$283,463
T32 · FY2025 · AI · contact PI
Structure-based microbially targeted prodrugs$798,784
R01 · FY2024 · AI · contact PI
Breathprinting as a window into gut microbiome chemoecology$669,712
R01 · FY2024 · HD · contact PI
MEP pathway resistance in Plasmodium falciparum$452,490
R01 · FY2024 · AI · contact PI
Combined Adult and Pediatric Infectious Disease Postdoctoral Training Grant$250,545
T32 · FY2024 · AI · contact PI
Diagnosis of MIS-C in febrile children$1,565,422
R33 · FY2023 · HD · contact PI
Diagnosis of MIS-C in febrile children$1,329,345
R33 · FY2023 · HD · contact PI
Structure-based microbially targeted prodrugs$816,384
R01 · FY2023 · AI · contact PI
Breathprinting as a window into gut microbiome chemoecology$709,733
R01 · FY2023 · HD · contact PI
MEP pathway resistance in Plasmodium falciparum$472,425
R01 · FY2023 · AI · contact PI
Combined Adult and Pediatric Infectious Disease Postdoctoral Training Grant$234,803
T32 · FY2023 · AI · contact PI
Structure-based microbially targeted prodrugs$874,128
R01 · FY2022 · AI · contact PI
Diagnosis of MIS-C in febrile children$871,132
R61 · FY2022 · HD · contact PI
Breathprinting as a window into gut microbiome chemoecology$734,664
R01 · FY2022 · HD · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$423,000
R01 · FY2022 · AI · contact PI
Combined Adult and Pediatric Infectious Disease Postdoctoral Training Grant$235,840
T32 · FY2022 · AI · contact PI
Diagnosis of MIS-C in febrile children$879,259
R61 · FY2021 · HD · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$423,000
R01 · FY2021 · AI · contact PI
Microbial Origin of Breath Volatile Metabolites$208,438
R21 · FY2021 · AI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$423,000
R01 · FY2020 · AI · contact PI
Microbial Origin of Breath Volatile Metabolites$264,459
R21 · FY2020 · AI
Towards noninvasive diagnosis of malaria$188,226
R21 · FY2020 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$370,125
R01 · FY2019 · AI · contact PI
Towards noninvasive diagnosis of malaria$297,059
R21 · FY2019 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$383,250
R01 · FY2018 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$342,000
R01 · FY2017 · AI · contact PI
TARGETING ISPC TO TREAT MALARIA$187,754
R21 · FY2017 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$342,000
R01 · FY2016 · AI · contact PI
TARGETING ISPC TO TREAT MALARIA$252,264
R21 · FY2016 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$342,000
R01 · FY2015 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$342,000
R01 · FY2014 · AI · contact PI
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM$315,614
R01 · FY2013 · AI · contact PI
Targeting isoprenoid biosynthesis in Plasmodium falciparum$108,662
K08 · FY2011 · AI · contact PI
GE AKTAEXPLORER CHROMOTOGRAPHY SYSTEM$121,776
S10 · FY2010 · RR · contact PI
Targeting isoprenoid biosynthesis in Plasmodium falciparum$113,964
K08 · FY2010 · AI · contact PI
Targeting isoprenoid biosynthesis in Plasmodium falciparum$42,294
K08 · FY2010 · AI · contact PI
Targeting isoprenoid biosynthesis in Plasmodium falciparum$111,273
K08 · FY2009 · AI · contact PI
Targeting isoprenoid biosynthesis in Plasmodium falciparum$48,826
K08 · FY2009 · AI · contact PI
Targeting isoprenoid biosynthesis in Plasmodium falciparum$87,062
K08 · FY2008 · AI · contact PI